Good Hope Works is an exciting creative research project facilitated by GOSH Arts and undertaken by artist Joanna Brinton. The project has engaged staff from across Great Ormond Street Hospital (GOSH) and will culminate in the installation of a permanent artwork at the entrance of the hospital.
Sir Michael Rake, currently Chairman of the BT Group plc, has been appointed as the new Chairman of Great Ormond Street Hospital for Children NHS Foundation Trust and will take up the position in November 2017.
Cystic fibrosis related diabetes (CFRD) is different to other types of diabetes. CFRD is caused by the build up of thick secretions in the pancreas. These secretions damage the cells that produce a hormone called insulin.
New onset diabetes after transplant (NODAT) affects between three and 13 per cent of children and young people who have an organ transplant. The medicines needed to prevent the body rejecting the organ also affect insulin production and uptake.
The Department of Endocrinology and Diabetes at Great Ormond Street Hospital (GOSH), in partnership with adolescent and adult services at University College London Hospitals (UCLH), form the London Centre for Paediatric Endocrinology and Diabetes.
A patient at Great Ormond Street Hospital (GOSH) has just become the first child in the UK, and the fifth in the world, to be fitted with a second generation DiaPort System, adapted to deliver insulin directly into the abdomen, bypassing the skin.
An experienced and accomplished healthcare leader, with a passion for child health and well-being, has been appointed the Deputy Chief Executive of Great Ormond Street Hospital for Children NHS Foundation Trust.
Healthcare associated infections (HCAI) are the most frequent adverse event during care delivery and are a global problem for patient safety. The prevention and management of the risk of HCAIs is an essential part of maintaining patient safety and fundamental in any healthcare setting (World Health Organisation (WHO), 2011).
This page fromGreat Ormond Street Hospital (GOSH) explains about helping your child with congenital heart disease to stay healthy and provides some information to help them flourish. Other sources where more detailed information can be found are also given.
The ketogenic diet (KD) is a therapeutic diet, which has been shown to improve seizure control in patients with drug resistant epilepsy, and is used in some patients with metabolic conditions for example, glucose transporter type 1 deficiency syndrome (GLUT1) and pyruvate dehydrogenase deficiency (PDH).